Allan GM - Search Results

1

Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for design.

Allan GM, Vicker N, Lawrence HR, Tutill HJ, Day JM, Huchet M, Ferrandis E, Reed MJ, Purohit A, Potter BV. Allan GM, et al. Bioorg Med Chem. 2008 Apr 15;16(8):4438-56. doi: 10.1016/j.bmc.2008.02.059. Epub 2008 Mar 7. Bioorg Med Chem. 2008. PMID: 18329273

2

The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.

Purohit A, Tutill HJ, Day JM, Chander SK, Lawrence HR, Allan GM, Fischer DS, Vicker N, Newman SP, Potter BV, Reed MJ. Purohit A, et al. Among authors: allan gm. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):199-203. doi: 10.1016/j.mce.2005.12.003. Epub 2006 Jan 18. Mol Cell Endocrinol. 2006. PMID: 16414180

3

Novel and potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors.

Lawrence HR, Vicker N, Allan GM, Smith A, Mahon MF, Tutill HJ, Purohit A, Reed MJ, Potter BV. Lawrence HR, et al. Among authors: allan gm. J Med Chem. 2005 Apr 21;48(8):2759-62. doi: 10.1021/jm049045r. J Med Chem. 2005. PMID: 15828812

4

E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Fischer DS, Allan GM, Bubert C, Vicker N, Smith A, Tutill HJ, Purohit A, Wood L, Packham G, Mahon MF, Reed MJ, Potter BV. Fischer DS, et al. Among authors: allan gm. J Med Chem. 2005 Sep 8;48(18):5749-70. doi: 10.1021/jm050348a. J Med Chem. 2005. PMID: 16134943

5

Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Allan GM, Bubert C, Vicker N, Smith A, Tutill HJ, Purohit A, Reed MJ, Potter BV. Allan GM, et al. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):204-7. doi: 10.1016/j.mce.2005.10.021. Epub 2005 Dec 7. Mol Cell Endocrinol. 2006. PMID: 16337736

6

Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Allan GM, Lawrence HR, Cornet J, Bubert C, Fischer DS, Vicker N, Smith A, Tutill HJ, Purohit A, Day JM, Mahon MF, Reed MJ, Potter BV. Allan GM, et al. J Med Chem. 2006 Feb 23;49(4):1325-45. doi: 10.1021/jm050830t. J Med Chem. 2006. PMID: 16480268

7

Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

Vicker N, Lawrence HR, Allan GM, Bubert C, Smith A, Tutill HJ, Purohit A, Day JM, Mahon MF, Reed MJ, Potter BV. Vicker N, et al. Among authors: allan gm. ChemMedChem. 2006 Apr;1(4):464-81. doi: 10.1002/cmdc.200500087. ChemMedChem. 2006. PMID: 16892382

8

17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer.

Day JM, Foster PA, Tutill HJ, Parsons MF, Newman SP, Chander SK, Allan GM, Lawrence HR, Vicker N, Potter BV, Reed MJ, Purohit A. Day JM, et al. Among authors: allan gm. Int J Cancer. 2008 May 1;122(9):1931-40. doi: 10.1002/ijc.23350. Int J Cancer. 2008. PMID: 18183589

9

Topical corticosteroids for atopic dermatitis.

Braschi É, Young J, Allan GM. Braschi É, et al. Among authors: allan gm. Can Fam Physician. 2024 Sep;70(9):558. doi: 10.46747/cfp.7009558. Can Fam Physician. 2024. PMID: 39271213 Free PMC article. No abstract available.

10

Response.

Kolber MR, Lindblad AJ, Klarenbach S, Allan GM. Kolber MR, et al. Among authors: allan gm. Can Fam Physician. 2024 Jun;70(6):371. doi: 10.46747/cfp.7006371_1. Can Fam Physician. 2024. PMID: 38886080 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters